Int J Curr Pharm Res, Vol 16, Issue 5, 61-64Original Article

SEROPREVALENCE OF HUMAN BRUCELLOSIS AMONG THE HIGH-RISK POPULATION

K. LAVANYA, B. SRI VANI VIJAYA SUBHASHINI*, P. KAMALA

*Department of Microbiology, Andhra Medical College, Visakhapatnam. Andhra Pradesh, India, 530001
*Corresponding author: B. Sri Vani Vijaya Subhashini; Email: bsvvsubhashini@gmail.com

Received: 28 Jun 2024, Revised and Accepted: 12 Aug 2024


ABSTRACT

Objective: Brucellosis is a zoonotic disease of worldwide distribution and has great economic concern. It is a contagious disease of ruminant animals but also effects human beings. The duration of the disease can vary from a few weeks to many months.

Methods: A total number of 200 samples tested for RBPT and STAT by using phenol saline as diluent to know the IgG titre and 2-mercaptoethanol was used as diluents to know the IgM titre. ELISA test performed for all positive samples in RBPT, to know the presence of IgM antibody. All the results were analyzed statistically.

Results: Of the 200 serum samples, highest proportion of positive cases were slaughter house worker 21.05% distribution according to positivity of RBPT and STST highest proportion in slaughter house workers 13.5% and lowest proportion in PUO cases 6.97%.

Conclusion: Prevention of human brucellosis focuses mainly on elimination of infection among farm animals. Cooperation is recommended between public health and veterinary officials to overcome the failure of controlling disease among both animals and humans.

Keywords: Human brucellosis, RBPT, STAT, ELISA, and IgM antibody


INTRODUCTION

Brucellosis is one of the world’s major zoonosis that continues to be public health and economic concern in many parts of the world [1]. It is transmitted directly or indirectly to humans from infected animals to humans by direct contact or by consumption of raw milk infected with Brucella [2]. Brucella organism shed in milk, urine and vaginal discharge, thereby contaminate environment. The infection occurs through the ingestion of raw milk of infected animals, contact with vaginal secretion, urine, faeces and blood of infected animals through un-breached skin and mucous membrane of conjunctiva and also by inhalation. Other modes of transmission are travel from or to endemic zones, person-to-person transmission through blood transfusion, organ transplant, and bone marrow transplant [3]. Brucellosis is an infectious zoonotic disease of various animals and humans caused by Brucella species. It is a contagious disease of ruminant animals but also affects human beings [4].

Brucellosis is also known as “undulant fever,” “Mediterranean fever,” or “Malta fever.” David Bruce (1887) a pathologist working in the British army, first isolated the organism during Malta fever outbreak among British soldiers. He also established the linking of fever in brucellosis patients due to the consumption of unpasteurized goat milk. Alice Evans, an American microbiologist suggested the name “Brucellosis” in 1918 in honor of Bruce [5, 6].

About 69% of the Indian population live in approximately 649,481 villages where people are in close approximation with cattle. The development of agriculture and incorporation of animal husbandry is responsible for the proximity of man and animals even today in many developing countries, including India. This proximity has led to the transmission of various zoonoses, including brucellosis from animals to man [7]. The prevalent species involved in human disease are Brucella melitensis and Brucella abortus; the former species is responsible for severe and prolonged disease with resultant disability [8]. The duration of the disease can vary from a few weeks to many months. Veterinarians are usually infected by inadvertent inoculation of animal vaccines against Brucella melitensis and Brucella abortus [9]. Its clinical manifestations and focal complications are often troublesome in making a clinical diagnosis. Its diagnosis, therefore requires microbiological confirmation by means of isolation from blood or demonstration of the presence of specific antibodies by serological tests [10, 11].

Brucella acts as a potential agent of bioterrorism and remains on the category B biodefense research list of both the Centers for Disease Control and Prevention and the National Institute of Allergy and Infectious Diseases. Its propensity for airborne transmission and induction of chronic debilitating disease requiring combined antibiotic regimens for treatment, its abundance around the world and its vague clinical characteristics defying rapid clinical diagnosis are some of the characteristics that apply to the pathogen’s weapons potential [12]. B. melitensis and Brucella suis are developed as biological weapons in several countries [12].

India is an agricultural country and exposure of human beings to animals is quite high [13]. Despite this, very limited studies on brucellosis have been undertaken in an occupationally exposed group. There are very few reports of Brucella in recent years even though it is discovered in 19th century.

AIM

The aim of present study was to know the seroprevalence of human brucellosis and evaluation of seroprevalence of human brucellosis and evaluation of serological tests for the diagnosis of brucellosis.

MATERIALS AND METHODS

Study design

The present study was done in the department of Microbiology, Andhra Medical College, Visakhapatnam over a period of 6 mo from July 2023 to December 2023. The study was approved by Institutional Ethics Committee.

Statistical analysis

Data collected was entered into Microsoft Excel-2010 version. Descriptive variables will be expressed in numbers and percentages. Continuous variables will be expressed as means± standard deviation. Statistical test-Chi square test will used for analyzing qualitative variable and student ‘t’ test for quantitative variable. For all statistical purposes, P value<0.05 was considered statistically significant.

Methodology

Blood samples were collected from different study groups like veterinary doctors, veterinary staff, slaughter house workers, dairy farm workers, patients with pyrexia of unknown origin and blood donors. Consent was taken from the entire study group.

Processing of samples

The cross-sectional study was carried out in Serology section of the Department of Microbiology. A total number of 200 blood samples were collected. Among them 119 were veterinarians, 38 were slaughter houses and dairy farm workers and 43 were PUO cases. A detailed history of individuals was taken which included the name, age, history of consumption of raw milk, history of fever in the past and complaints of joint pains, if any.

For all the blood samples classical Rose Bengal test was performed. Standard tube agglutination test was done for all positives in RBPT by using phenol saline as diluent to know the IgG titre and 2-mercapto ethanol was used as diluents to know the IgM titre. ELISA test was performed for all positive samples in RBPT, to know the presence of IgM antibody [14]. All the results were analyzed statistically.

RESULTS

A total number of 200 patients were recruited during the study, of which they are categorized into three groups like: veterinarians 119, slaughter house workers and dairy farm workers 38 and patients with Pyrexia of unknown origin 43. The age group ranges from 21-60 years. Majority of positive samples are seen in age group of 31-40 y with male preponderance

Distribution of cases according to positivity of RBPT and STAT, highest proportion of positive cases in slaughter house and dairy farm workers (13.5%) and lowest proportion in PUO cases (6.97%). The prevalence of brucellosis by 2 Mercaptoethanol Standard tube agglutination test was highest in slaughter house and dairy farm workers (7.89%) and lowest in PUO cases (2.32%). Distribution of cases according to results of IgM ELISA, highest proportion of positive cases was present in slaughterhouse and dairy farm workers (21.05%) and lowest prevalence rate in PUO cases (6.97%).

Results are analyzed by using chi-square test. P value> 0.05 for RBPT, STAT, STAT with 2 ME. So, the difference in the positivity in all these is not significant among the occupational groups. P value<0.05 for IgM ELISA. So, IgM ELISA test positivity is significant among occupational groups.

Table 1: Positivity of serological tests among patient groups

Group Number (n= 200) RBPT+ve % STAT with phenol saline %
Group I: Veterinarians 119 (59.5%) 10 8.4% 10 8.4%
Group II: Slaughter house workers 38 (19%) 5 13.5% 5 13.5%
Group II: PUO’s 43 (21.5%) 3 6.97% 3 6.97%

Table shows highest positivity of RBPT (13.5%), STAT (13.5%) in slaughter house workers.

Table 2: Positivity of serological tests among patient groups

Group Number (n= 200) STAT with 2ME+ve % IgM ELISA %
Group I: Veterinarians 119 (59.5%) 8 6.72 11 9.24
Group II: Slaughter house workers 38 (19%) 3 7.89 8 21.05
Group II: PUO’s 43 (21.5%) 1 2.32 3 6.79

Table shows highest positivity of STAT with 2ME (7.89%) and IgM ELISA (21.05%) in slaughter house workers.

DISCUSSION

Worldwide millions of persons are at risk of acquiring brucellosis, especially in developing countries, where the infection in animals has not been under control, and mismanagement of animal quarantine eradication of infected animal [15]. It has been estimated that the incidence in humans ranges widely between different regions, with values of up to 200 cases per 1 lakh populations. Clinical picture of brucellosis in man is very heterogenous and nonspecific which may be represented in both subclinical and atypical infection either in acute or chronic stage [16, 17]. So, the diagnosis of brucellosis requires laboratory confirmation or isolation of the pathogen or determination of specific antibodies [18].

Furthermore, handling of these microorganisms represents a high risk for laboratory personnel [19]. The most widely used serological tests for diagnosis of brucellosis are agglutination tests; however, indirect enzyme-linked immune sorbent assay (iELISA) was documented as the most sensitive test [20]. The highest incidence of brucellosis was reported in this study by IgM ELISA (11%) may be due to occupational exposure among veterinary staff and handling of animals among the rural group. Higher prevalence rates were reported by Modak D., et al. 2024 (15.8%) [21]. However lower rates were detected by Mousa et al. (0.08%) [22] Dajani et al. (0.04%) [23] and Shome R et al. (0.92%) [24].

The detection of specific IgM antibody is important to diagnose brucellosis in the early phase. IgM antibodies were estimated in 200 screened cases (11%). These findings are similar to that reported by Shukla et al. 2022 (11.37%) [25] Soliman et al. 1998 (10.9%) [2] Mrunalini N et al. 2004 (11.5%) [26]. The present study was divided into 3 groups among them veterinary staff are in high proportion and PUO cases are in lower proportion. In this study age distribution of group 1 veterinarians, group 2 slaughterhouse workers and dairy farm workers, group 3 pyrexia of unknown origin cases were from 21 to above 60 y. Regarding the prevalence of brucellosis among different age groups, there is highest percentage of patients with age 31-40 y (35.5%) and the lowest percentage of patients with age 51-60 y (11.5%) by agglutination tests. However, the same prevalence by ELISA in both the age groups of 31-40 y correlated with studies of Shukla et al. (2022) [25]. In study conducted by Agasthya et al. (2007) [15]. The highest prevalence was found among 41-50 y age group (45.36%) and the lowest prevalence was found among 21-30 y (7.21%) and Study conducted by Modak D., et al. (2024) [21] found that highest prevalence rates was found among 51-60 y (23.5%) and lowest prevalence was seen in age group of 21-30 y (8.8%) 22 patients were brucella positive by IgM ELISA. In that (12.28%) were males and (6.89%) were females. The seropositivity is higher in males compared to females in this study due to higher exposure to risk factors. But the study conducted by Modak. D. et al. (2024) [21] reported high positivity in females (14.8%) than males (10.9%). In this study, a smaller number of females was taken than males. So, difference in seropositivity between males and females is statistically not significant.

In this study 200 patients were tested by RBPT, 18 Samples (9%) were positive. The study was correlated with study of Sharma H. K. et al. (9.91%) [27]. Study conducted by Modak D. et al., [21] reported higher positivity of RBPT test results (18.5%). Cifti C. et al. (2005) [10] compared slide agglutination, standard tube agglutination test and comb tube agglutination test. Kumar P et al. (1997) [28] compared the serum samples by using slide agglutination test and standard tube agglutination test. He stated that slide agglutination was positive in 12.75%.

In our study the Rose Bengal plate test was positive in 9%. It is less than that of IgM ELISA (11%) used in our study. This was consistent with the findings of Sharma H. K. et al. [27] (9.91%, 16.52%). 200 serum samples were tested and a significant antibody titre of>160 IU was detected in 18 samples (9%). In kumar P et al. (1997) [28] study the standard tube agglutination test was positive in 50.30% samples. In other studies, like that of Modak D. et al. (2024) [21] showed that STAT was positive in 15.5% among the serum samples. Our study used STAT and detected lesser number of positive cases when compared to ELISA IgG and IgM. This conquers agreement with the results of Pathak A. et al. (2014) [29] and Sharma HK et al. (2016) [27].

IgM antibodies were estimated in 200 screened cases (11%). These findings agree with that reported by Diaz et al. (1991) [11] and Ariza et al. (1992) [30]. Annapurna SA et al. (2012) [14]. Agasthya et al. (2011) [15] compared Brucella indirect ELISA test with RBPT and STAT. In this study, by indirect ELISA detected 20 samples positive (3.6%), which are negative by RBPT and STAT. M. O. Gad EL-Rab et al. (1998) [31] compared Brucella ELISA test with Brucella culture and STAT. In his study IgM ELISA detected lesser number than other serological techniques.

Our results revealed that the prevalence of brucellosis was significantly higher in rural areas (13.07%) than in urban areas (7.14%). These findings coincide with that reported by Kumar A. et al. (2010) [32], Kavi A. et al. (2015) [33] and Mangalgi SS. et al. (2015) [34] who concluded that the higher prevalence in rural areas may be due to close contact of individuals with livestock. This is a concordance between that results of IgM ELISA with RBPT and STAT with only insignificant difference of 2%.

In controls among 50 individuals 1(2%) had RBPT positive>160IU in standard tube agglutination test. 22 were positive by IgM ELISA. Of these, 18 had significant antibody titre of>160 IU by standard tube agglutination test also. Geographical variation was found between different regions.

CONCLUSION

This study was done to diagnose the brucellosis in high-risk groups. Persistence of animal reservoir of infection, low physician awareness, poor availability of diagnostic facilities and non-existence of regional databases contributes towards the perpetuation of the zoonosis in India. The cases of brucellosis may be easily misdiagnosed because of the deceptive nature of the clinical signs and symptoms. High degree of cure rate can be achieved by treatment, which is otherwise having high degree of mortality and morbidity. Prevention of human brucellosis focuses mainly on elimination of infection among farm animals. Cooperation is recommended between public health and veterinary officials to overcome the failure of controlling disease among both animals and humans. IgM ELISA antibody detection is the sensitive and specific test of choice in the diagnosis of patients with acute brucellosis.

ACKNOWLEDGEMENT

We would like to thank several people who made significant contributions to the completion of this research publication. This experiment would not have been possible without the assistance of the whole medical personnel of the different study groups like veterinary doctors, veterinary staff, slaughterhouse workers, dairy farm workers, patients with pyrexia of unknown origin and blood donors. Additionally, we want to express our gratitude to the study participants who voluntarily and without hesitation provided us with all the information we required.

FUNDING

Nil

AUTHORS CONTRIBUTIONS

All the authors have contributed equally

CONFLICT OF INTERESTS

The author(s) have no competing interests for financial support, publication of this research, patents and royalties through this collaborative research. All authors were equally involved in discussed research work. There is no financial conflict with the subject matter discussed in the manuscript.

REFERENCES

  1. Corbel MJ, Nations F and AO of the U, World Health Organization, Health WO for A. Brucellosis in Humans and Animals. World Health Organization; 2006. Available from: https://apps.who.int/iris/handle/10665/43597 [Last accessed on 03 May 2021]

  2. Soliman SA. Studies on brucellosis in farm animals with reference to public health importance in animals with reference to public health importance in Suez Canal District PhD thesis, for Med-Suez–Canal Univ; 1998.

  3. Kapoor PK, Sharma SN Rao KL. Seroprevalence of brucellosis in goats and human being in Bianer (Rajasthan). Ind J Compiler Microbial Immunol infect Dis. 1985;6:96-101.

  4. Gwida M, Al Dahouk S, Melzer F, Rosler U, Neubauer H, Tomaso H. Brucellosis regionally emerging zoonotic disease. Croat Med J. 2010;51(4):289-95. doi: 10.3325/cmj.2010.51.289, PMID 20718081.

  5. Zammit T. Apreliminary note on the examination of blood of goats suffering from mediterranean fever report of the commission on mediterranean fever part iii London: Harrison & Sons; 1905. p. 83.

  6. Horrocks WH, Kennedy JC. Goats as a means of propagation of mediterranean fever repoert of the commission on mediterranean fever part iv London: Harrison & Sons; 1906. p. 37-69.

  7. Rossetti CA, Arenas Gamboa AM, Maurizio E. Caprine brucellosis: a historically neglected disease with significant impact on public health. PLOS Negl Trop Dis. 2017;11(8):e0005692. doi: 10.1371/journal.pntd.0005692, PMID 28817647.

  8. Colmenero JD, Reguera JM, Martos F, Sanchez De Mora D, Delgado M, Causse M. Complications associated with brucella melitensis infection: a study of 530 cases. Med (Baltim). 1996;75(4):195-211. doi: 10.1097/00005792-199607000-00003, PMID 8699960.

  9. Olsen SC. Recent developments in livestock and wildlife brucellosis vaccination: EN FR evolutions recentes de la vaccination des animaux delevage et sauvages contre la brucellose ES evolucion reciente de la vacunacion antibrucelica del ganado y la fauna salvaje. Rev Sci Tech OIE. 2013;32(1):207-17. doi: 10.20506/rst.32.1.2201.

  10. Cifti C, Ozturk F, Oztekin A, Karaoglan H, Saba R, Gultekin M. Comparison of the serological tests used for the laboratory diagnosis of brucellosis. Microbiol Bul. 2005 Jul;39(3):291-9.

  11. Diaz R, Moriyan I. Laboratory techniques in the diagnosis. In: MJ editor brucellosis: clinical and laboratory aspects young e. j. and corbel boca raton FL: CRC Press; 1989. p. 73-83.

  12. Pappas G, Panagopoulou P, Christou L, Akritidis N. Brucella as a biological weapon. Cell Mol Life Sci. 2006;63(19-20):2229-36. doi: 10.1007/s00018-006-6311-4, PMID 16964579.

  13. Mohanty TN, Panda SN, Das BR, Pradhan SK, Pradhan RK. Sero incidence of brucellosis among dairy farm workers in Orissa. Indian Vet J. 2000;77:568-70.

  14. Annapurna SA, Joshi M. Serodiagnosis of brucellosis conventional and molecular approach. Asian Journal of Microbiology Biotechnology and Environmental Sciences. 2012;14(4):583-690.

  15. Agasthya AS, Isloor S, Prabhudas K. Brucellosis in high-risk group individuals. Indian J Med Microbiol. 2007;25(1):28-31. doi: 10.4103/0255-0857.31058, PMID 17377349.

  16. Zhen Q, Lu Y, Yuan X, Qiu Y, Xu J, Li W. Asymptomatic brucellosis infection in humans: implications for diagnosis and prevention. Clin Microbiol Infect. 2013;19(9):E395-7. doi: 10.1111/1469-0691.12250, PMID 23668532.

  17. Edathodu J, Alamri M, Alshangiti KA, Alfagyh NS, Alnaghmush AS, Albaiz F. Clinical manifestations and treatment outcomes of human brucellosis at a tertiary care center in Saudi Arabia. Ann Saudi Med. 2021;41(2):109-14. doi: 10.5144/0256-4947.2021.109, PMID 33818142.

  18. Kaltungo BY, Saidu SN, Sackey AK, Kazeem HM. A review on diagnostic techniques for brucellosis. Afr J Biotechnol. 2014;12(1):1-10.

  19. Noviello S, Gallo R, Kelly M, Limberger RJ, DeAngelis K, Cain L. Laboratory acquired brucellosis. Emerg Infect Dis. 2004;10(10):1848-50. doi: 10.3201/eid1010.040076, PMID 15504276.

  20. Ferreira AC, Cardoso R, Travassos Dias I, Mariano I, Belo A, Rolao Preto I. Evaluation of a modified rose bengal test and an indirect enzyme-linked immunosorbent assay for the diagnosis of brucella melitensis infection in sheep. Vet Res. 2003;34(3):297-305. doi: 10.1051/vetres:2003005, PMID 12791239.

  21. Modak D, Biswas S, Mondal A, Biswas M, Mascellino MT, Chakraborty B. Seroprevalence of brucellosis among animal handlers in West Bengal India: an occupational health study. AIMS Microbiol. 2024;10(1):1-11. doi: 10.3934/microbiol.2024001, PMID 38525042.

  22. Mousa AR, Elhag KM, Khogali M, Marafie AA. The nature of human brucellosis in kuwait: study of 379 cases. Rev Infect Dis. 1988;10(1):211-17. doi: 10.1093/clinids/10.1.211, PMID 3353631.

  23. Dajani YF, Masoud AA, Barakat HF. Epidemiology and diagnosis of human brucellosis in Jordan. J Trop Med Hyg. 1989;92(3):209-14. PMID 2738993.

  24. Shome R, Kalleshamurthy T, Shankaranarayana PB, Giribattanvar P, Chandrasekhar N, Mohandoss N. Prevalence and risk fctors of brucellosis among veterinary health care professionals. Pathog Glob Health. 2017;111(5):234-9. doi: 10.1080/20477724.2017.1345366, PMID 28689480.

  25. Shukla JL, Husain AA, Lyngdoh SA, Nonglang FP, Sahai N, Gogoi M. Seroepidemiological study of human brucellosis in the Northeast region of Meghalaya India. J Family Med Prim Care. 2022;11(9):5176-86. doi: 10.4103/jfmpc.jfmpc_1705_21, PMID 36505523.

  26. Mrunalini N, Reddy MS, Ramasastry P, Rao MR. Seroepidemiology of human brucellosis in Andhra Pradesh. Indian Vet J. 2004;81(7):744-7.

  27. Sharma HK, Kotwal SK, Singh DK, Malik MA, Kumar A, Rajagunalan SM. Seroprevalence of human brucellosis in and around Jammu India, using different serological tests. Vet World. 2016;9(7):742-6. doi: 10.14202/vetworld.2016.742746, PMID 27536036.

  28. Kumar P, Singh DK, Barbuddhe SB. Seroprevalence of brucellosis among abattoir personnel of Delhi. J Commun Dis. 1997;29(2):131-7. PMID 9282512.

  29. Pathak AD, Dubal ZB, Doijad S, Raorane A, Rodrigues S, Naik R. Human brucellosis among pyrexia of unknown origin cases and occupationally exposed individuals in Goa Region India. Emerg Health Threats J. 2014;7:23846. doi: 10.3402/ehtj.v7.23846.

  30. Ariza J, Pellicer T, Pallares R, Foz A, Gudiol F. Specific antibody profile in human brucellosis. Clin Infect Dis. 1992;14(1):131-40. doi: 10.1093/clinids/14.1.131, PMID 1571417.

  31. Gad El Rab MO, Kambal AM. Evaluation of a brucelle enzyme immunoassay test (ELISA) in comparison with bacteriological culture and agglutination. J Infect. 1998;36(2):197-201. doi: 10.1016/S0163-4453(98)80013-3.

  32. Kumar A. Brucellosis: need of public health intervention in rural India. Prilozi. 2010;31(1):219-31. PMID 20703194.

  33. Kavi A, Shivamallappa SM, Metgud SC, Patil VD. An epidemiological study of brucellosis in rural area of North Karnataka. Int J Med Sci Public Health. 2015;4(9):1197-201. doi: 10.5455/ijmsph.2015.20032015248.

  34. Mangalgi SS, Sajjan AG, Mohite ST, Kakade SV. Serological clinical and epidemiological profile of human brucellosis in rural India. Indian J Community Med. 2015;40(3):163-7. doi: 10.4103/0970-0218.158847, PMID 26170539.

  35. Ghugey SL, Setia MS, Deshmukh JS. Human brucellosis: seroprevalence and associated exposure factors among the rural population in Nagpur Maharashtra India. J Family Med Prim Care. 2021;10(2):1028-33. doi: 10.4103/jfmpc.jfmpc_1153_20, PMID 34041116.

  36. Stephen S, Pradeep J, Sangeetha B, Jayaraman S. Seroprevalence of human brucellosis in and around puducherry: application of an immunocapture agglutination technique (brucellacapt). J Pure Appl Microbiol. 2019;13(1):313-7. doi: 10.22207/JPAM.13.1.34.